Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 14;41(1):1-10.
doi: 10.1055/s-0043-1778657. eCollection 2024 Feb.

SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know

Michael J Gutman  1 , Lucas M Serra  1 , Matthew Koshy  1 , Rohan R Katipally  1
Affiliations
Review

SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know

Michael J Gutman et al. Semin Intervent Radiol. .

Abstract

This review summarizes the clinical evidence supporting the utilization of stereotactic body radiotherapy (SBRT) for liver tumors, including hepatocellular carcinoma, liver metastases, and cholangiocarcinoma. Emerging prospective evidence has demonstrated the benefit and low rates of toxicity across a broad range of clinical contexts. We provide an introduction for the interventional radiologist, with a discussion of underlying themes such as tumor dose-response, mitigation of liver toxicity, and the technical considerations relevant to performing liver SBRT. Ultimately, we recommend that SBRT should be routinely included in the armamentarium of locoregional therapies for liver malignancies, alongside those liver-directed therapies offered by interventional radiology.

Keywords: HCC SBRT; interventional radiology; liver SBRT; stereotactic ablative radiotherapy; stereotactic body radiotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest M.J.G., L.M.S., M.K., and R.R.K. all report no conflicts of interest.

Similar articles

See all similar articles

References

    1. Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34(06):861–870. - PubMed
    1. Miften M, Vinogradskiy Y, Moiseenko V et al.Radiation dose-volume effects for liver SBRT. Int J Radiat Oncol Biol Phys. 2021;110(01):196–205. - PMC - PubMed
    1. Dawson L A, Normolle D, Balter J M, McGinn C J, Lawrence T S, Ten Haken R K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53(04):810–821. - PubMed
    1. Fowler J F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62(740):679–694. - PubMed
    1. Sung H, Ferlay J, Siegel R L et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(03):209–249. - PubMed